Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filmon Eyassu

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Royal Society Open Science|November 15, 2017
Modelling pyruvate dehydrogenase under hypoxia and its role in cancer metabolismFilmon Eyassu, Claudio Angione
BMC Systems Biology|November 28, 2017
MitoCore: a curated constraint-based model for simulating human central metabolismAnthony C Smith, Filmon Eyassu, Jean-Pierre Mazat, et al.
Peerj|December 28, 2018
In silico engineering of <i>Pseudomonas</i> metabolism reveals new biomarkers for increased biosurfactant productionAnnalisa Occhipinti, Filmon Eyassu, Thahira J Rahman, et al.
BMC Bioinformatics|December 1, 2018
CiliateGEM: an open-project and a tool for predictions of ciliate metabolic variations and experimental condition designAlessio Mancini, Filmon Eyassu, Maxwell Conway, et al.
Nature Communications|December 18, 2023
Potent latency reversal by Tat RNA-containing nanoparticle enables multi-omic analysis of the HIV-1 reservoirMarion Pardons, Basiel Cole, Laurens Lambrechts, et al.
Antimicrobial Agents and Chemotherapy|October 24, 2023
A truncated HIV Tat demonstrates potent and specific latency reversal activityEllen Van Gulck, Marion Pardons, Erik Nijs, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 9, 2018
Mitochondrial oxodicarboxylate carrier deficiency is associated with mitochondrial DNA depletion and spinal muscular atrophy-like diseaseVeronika Boczonadi, Martin S King, Anthony C Smith, et al.
Nature|November 11, 2014
Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROSEdward T Chouchani, Victoria R Pell, Edoardo Gaude, et al.
Blood|June 21, 2024
Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemiasMin Chul Kwon, Jan Willem Thuring, Olivier Querolle, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Royal Society Open Science|November 15, 2017
Modelling pyruvate dehydrogenase under hypoxia and its role in cancer metabolismFilmon Eyassu, Claudio Angione
BMC Systems Biology|November 28, 2017
MitoCore: a curated constraint-based model for simulating human central metabolismAnthony C Smith, Filmon Eyassu, Jean-Pierre Mazat, et al.
Peerj|December 28, 2018
In silico engineering of <i>Pseudomonas</i> metabolism reveals new biomarkers for increased biosurfactant productionAnnalisa Occhipinti, Filmon Eyassu, Thahira J Rahman, et al.
BMC Bioinformatics|December 1, 2018
CiliateGEM: an open-project and a tool for predictions of ciliate metabolic variations and experimental condition designAlessio Mancini, Filmon Eyassu, Maxwell Conway, et al.
Nature Communications|December 18, 2023
Potent latency reversal by Tat RNA-containing nanoparticle enables multi-omic analysis of the HIV-1 reservoirMarion Pardons, Basiel Cole, Laurens Lambrechts, et al.
Antimicrobial Agents and Chemotherapy|October 24, 2023
A truncated HIV Tat demonstrates potent and specific latency reversal activityEllen Van Gulck, Marion Pardons, Erik Nijs, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 9, 2018
Mitochondrial oxodicarboxylate carrier deficiency is associated with mitochondrial DNA depletion and spinal muscular atrophy-like diseaseVeronika Boczonadi, Martin S King, Anthony C Smith, et al.
Nature|November 11, 2014
Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROSEdward T Chouchani, Victoria R Pell, Edoardo Gaude, et al.
Blood|June 21, 2024
Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemiasMin Chul Kwon, Jan Willem Thuring, Olivier Querolle, et al.
Pageof 1